Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2024-04-25 14:08 Tx date 2024-04-12 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$80,423
+14,060 vol $5.72 each |
44,830 | |
Filed 2024-04-16 18:28 Tx date 2024-04-12 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$79,805
+14,001 vol $5.70 each |
||
Filed 2024-04-16 18:31 Tx date 2024-04-12 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
56 - Grant of rights
|
$27,525
+4,829 vol $5.70 each |
12,085 | |
Filed 2024-04-16 18:30 Tx date 2024-04-12 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$55,044
+9,657 vol $5.70 each |
24,171 | |
Filed 2024-04-16 18:28 Tx date 2024-04-12 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$79,805
+14,001 vol $5.70 each |
44,771 | |
Filed 2024-04-05 16:02 Tx date 2024-04-01 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$23,304
+4,397 vol $5.30 each |
4,397 | |
Filed 2024-04-05 16:00 Tx date 2021-09-01 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2024-04-05 15:56 Tx date 2024-04-01 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
57 - Exercise of rights
|
$-21,064.03
-4,043 vol $5.21 each |
14,514 | |
Filed 2024-04-05 15:54 Tx date 2024-04-01 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
57 - Exercise of rights
|
$-10,534.62
-2,022 vol $5.21 each |
7,256 | |
Filed 2024-04-05 15:44 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
97 - Other
|
$21,064
+4,043 vol $5.21 each |
4,043 | |
Filed 2024-04-05 15:41 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
97 - Other
|
$10,534
+2,022 vol $5.21 each |
2,022 | |
Filed 2022-09-15 09:44 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
97 - Other
|
$21,064
+4,043 vol $5.21 each |
||
Filed 2022-09-15 09:41 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
97 - Other
|
$10,534
+2,022 vol $5.21 each |
||
Filed 2022-04-27 10:24 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
97 - Other
|
$25,278
+4,852 vol $5.21 each |
||
Filed 2022-04-27 10:23 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
97 - Other
|
$12,639
+2,426 vol $5.21 each |
||
Filed 2022-01-06 16:01 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
97 - Other
|
$25,278
+4,852 vol $5.21 each |
||
Filed 2022-01-06 16:00 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
97 - Other
|
$12,639
+2,426 vol $5.21 each |
||
Filed 2021-12-10 13:52 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
97 - Other
|
$12,639
+2,426 vol $5.21 each |
||
Filed 2021-12-10 13:51 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
97 - Other
|
$25,278
+4,852 vol $5.21 each |
||
Filed 2021-12-10 13:41 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
97 - Other
|
$12,639
+2,426 vol $5.21 each |
||
Filed 2023-04-03 21:46 Tx date 2023-03-30 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
56 - Grant of rights
|
$18,949
+4,268 vol $4.44 each |
11,299 | |
Filed 2023-04-03 21:44 Tx date 2023-03-30 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$37,908
+8,538 vol $4.44 each |
16,536 | |
Filed 2023-04-03 21:43 Tx date 2023-03-30 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$61,054
+13,751 vol $4.44 each |
30,770 | |
Filed 2022-09-15 09:47 Tx date 2022-03-24 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
56 - Grant of rights
|
$15,567
+2,988 vol $5.21 each |
7,031 | |
Filed 2022-09-15 09:46 Tx date 2022-03-24 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$31,134
+5,976 vol $5.21 each |
7,998 | |
Filed 2022-09-15 09:44 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
97 - Other
|
$21,064
+4,043 vol $5.21 each |
4,043 | |
Filed 2022-09-15 09:41 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
97 - Other
|
$10,534
+2,022 vol $5.21 each |
2,022 | |
Filed 2022-09-15 09:27 Tx date 2022-03-24 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$53,131
+10,198 vol $5.21 each |
17,019 | |
Filed 2022-09-15 09:25 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$35,878
+6,821 vol $5.26 each |
6,821 | |
Filed 2022-04-27 10:24 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
97 - Other
|
$25,278
+4,852 vol $5.21 each |
||
Filed 2022-04-27 10:23 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
97 - Other
|
$12,639
+2,426 vol $5.21 each |
||
Filed 2022-03-29 11:32 Tx date 2022-03-24 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
56 - Grant of rights
|
$18,683
+3,586 vol $5.21 each |
||
Filed 2022-03-29 11:31 Tx date 2022-03-24 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$37,360
+7,171 vol $5.21 each |
||
Filed 2022-03-29 11:30 Tx date 2022-03-24 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$63,759
+12,238 vol $5.21 each |
||
Filed 2022-01-06 21:52 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$43,053
+8,185 vol $5.26 each |
||
Filed 2022-01-06 16:01 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
97 - Other
|
$25,278
+4,852 vol $5.21 each |
||
Filed 2022-01-06 16:00 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
97 - Other
|
$12,639
+2,426 vol $5.21 each |
||
Filed 2022-01-06 15:52 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$46,750
+8,888 vol $5.26 each |
||
Filed 2021-12-10 13:53 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$46,750
+8,888 vol $5.26 each |
||
Filed 2021-12-10 13:52 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
97 - Other
|
$12,639
+2,426 vol $5.21 each |
||
Filed 2021-12-10 13:51 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
97 - Other
|
$25,278
+4,852 vol $5.21 each |
||
Filed 2021-12-10 13:41 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
97 - Other
|
$12,639
+2,426 vol $5.21 each |
||
Filed 2022-04-27 10:24 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
97 - Other
|
$25,278
+4,852 vol $5.21 each |
4,852 | |
Filed 2022-04-27 10:23 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
97 - Other
|
$12,639
+2,426 vol $5.21 each |
2,426 | |
Filed 2022-01-06 16:01 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
97 - Other
|
$25,278
+4,852 vol $5.21 each |
||
Filed 2022-01-06 16:00 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
97 - Other
|
$12,639
+2,426 vol $5.21 each |
||
Filed 2021-12-10 13:52 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
97 - Other
|
$12,639
+2,426 vol $5.21 each |
||
Filed 2021-12-10 13:51 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
97 - Other
|
$25,278
+4,852 vol $5.21 each |
||
Filed 2021-12-10 13:41 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
97 - Other
|
$12,639
+2,426 vol $5.21 each |
||
Filed 2022-03-29 11:32 Tx date 2022-03-24 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
56 - Grant of rights
|
$18,683
+3,586 vol $5.21 each |
6,012 | |
Filed 2022-03-29 11:31 Tx date 2022-03-24 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$37,360
+7,171 vol $5.21 each |
12,023 | |
Filed 2022-03-29 11:30 Tx date 2022-03-24 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$63,759
+12,238 vol $5.21 each |
20,423 | |
Filed 2022-01-06 21:52 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$43,053
+8,185 vol $5.26 each |
8,185 | |
Filed 2022-01-06 16:01 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
97 - Other
|
$25,278
+4,852 vol $5.21 each |
4,852 | |
Filed 2022-01-06 16:00 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
97 - Other
|
$12,639
+2,426 vol $5.21 each |
2,426 | |
Filed 2022-01-06 15:52 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$46,750
+8,888 vol $5.26 each |
||
Filed 2022-01-06 15:52 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$46,750
+8,888 vol $5.26 each |
8,888 | |
Filed 2021-12-10 13:53 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$46,750
+8,888 vol $5.26 each |
||
Filed 2021-12-10 13:53 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$46,750
+8,888 vol $5.26 each |
||
Filed 2021-12-10 13:52 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
97 - Other
|
$12,639
+2,426 vol $5.21 each |
||
Filed 2021-12-10 13:51 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
97 - Other
|
$25,278
+4,852 vol $5.21 each |
||
Filed 2021-12-10 13:41 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
97 - Other
|
$12,639
+2,426 vol $5.21 each |
||
Filed 2021-12-10 13:53 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$46,750
+8,888 vol $5.26 each |
8,888 | |
Filed 2021-12-10 13:52 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
97 - Other
|
$12,639
+2,426 vol $5.21 each |
2,426 | |
Filed 2021-12-10 13:51 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
97 - Other
|
$25,278
+4,852 vol $5.21 each |
4,852 | |
Filed 2021-12-10 13:49 Tx date 2021-09-01 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-12-10 13:41 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
97 - Other
|
$12,639
+2,426 vol $5.21 each |
||
Filed 2021-12-10 13:28 Tx date 2021-09-01 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-12-10 13:26 Tx date 2021-09-01 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|